Study of Peripheral Arterial Disease (PAD) in People With Cancer Who Will Be Having Surgery

Active, not recruitingOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Peripheral Arterial Disease (PAD) in Cancer Patients
Interventions
DIAGNOSTIC_TEST

ABI/TBI

ABI/TBI to be performed after surgery while patient is still admitted at the hospital.

OTHER

Questionnaires

PAD symptoms questionnaire to be administered at baseline before surgery. mLEFS (included in PAD symptoms questionnaire) and WIQ to be administered at baseline before surgery. mLEFS and WIQ will be administered 1 month, 3 months, 6 months after surgery and every 6 months after that for a goal of at least 1 year.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

All Listed Sponsors
collaborator

BMS Foundation

UNKNOWN

lead

Memorial Sloan Kettering Cancer Center

OTHER